Nomogram for Uveal Melanoma Predicts VA: Using point system can better determine risk of poor outcomes.

The article reports that the researchers recently developed a nomogram that may help clinicians predict visual acuity outcomes for patients with uveal melanoma undergoing plaque radiotherapy and prophylactic intravitreal anti-vascular endothelial growth factor (VEGF). It mentions that the team used two point systems for visual acuity outcome—one with clinical risk factors and the other with both clinical and treatment risk factors.